PROTHENA CORP PUBLIC LTD CO
PRTA · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Scully William P: Form 4
Insider disclosure · Filed · Report period 13 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- PRTA · G72800108 - Ordinary Shares, $0.01 par value
Company details and SEC sources
CIK 0001559053 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- PRTA on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 77 Sir John Rogerson's Quay, Block C, Grand Canal Docklands, Dublin 2, Ireland, D02 VK60
- Incorporated in
- Ireland
- Fiscal year end
- 31 December
- Former names on EDGAR
- Prothena Corp plc (to 22 May 2020), Neotope Corp Ltd (to 01 Oct 2012)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields